Predictive Oncology Inc. (POAI)
1.47
0.02 (1.38%)
At close: Mar 31, 2025, 11:32 AM
Predictive Oncology Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 1.78M | 1.51M | 1.42M | 1.25M | 1.41M | 1.41M | 654.84K | 456.5K | 654.35K | 951.56K | 468.13K | 188.77K | 96.64K | 288.00 | 15.74K | n/a |
| Cost of Revenue | 634.8K | 505.11K | 487.02K | 447.19K | 531.81K | 415.76K | 148.04K | 181.62K | 303.98K | 385.32K | 189.71K | 128.54K | 56.08K | 140.00 | 7K | n/a |
| Gross Profit | 1.15M | 1M | 933.66K | 805.08K | 879.75K | 995.89K | 506.79K | 274.88K | 350.37K | 566.24K | 278.42K | 60.23K | 40.56K | 148.00 | 8.74K | n/a |
| Operating Income | -14.08M | -15.27M | -13.47M | -666.27K | -13.77M | -7.86M | -7.75M | -6.53M | -4.4M | -6.47M | -8.93M | -7.16M | -4.11M | -1.21M | -2.44M | -1.67M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -13.98M | -25.74M | -20.32M | -25.88M | -19.39M | -10.09M | -7.75M | -6.53M | -4.79M | -6.83M | -9.41M | -7.42M | -4.49M | -1.35M | -1.76M | n/a |
| Net Income | -13.98M | -36.21M | -19.66M | -37.7M | -27.56M | -10.09M | -7.75M | -6.53M | -4.79M | -6.83M | -9.41M | -7.42M | -4.49M | -1.35M | -2.89M | -1.76M |
| Selling & General & Admin | 15.07M | 12.47M | 11.71M | 10.94M | 11.69M | 7M | 8.25M | 5.64M | 4.75M | 7.03M | 9.21M | 7.22M | 4.15M | 2.07M | 2.01M | 1.35M |
| Research & Development | 188.31K | 320.32K | 315.85K | 2.35M | 2.96M | 1.86M | 289K | 406K | 261K | 394K | 235.05K | 15K | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | 3.8M | 2.7M | -1.58M | -2.47M | 68.48K | n/a | 1.16M | n/a | n/a | n/a | n/a | n/a | -868.29K | 447K | n/a |
| Operating Expenses | 15.23M | 16.27M | 14.41M | 13.29M | 14.65M | 8.86M | 8.25M | 6.8M | 4.75M | 7.03M | 9.21M | 7.22M | 4.15M | 1.21M | 2.45M | 1.67M |
| Interest Expense | n/a | 10.65M | n/a | n/a | n/a | n/a | n/a | 3.00 | 390.89K | 377.72K | 636.5K | 259.35K | 230.37K | 147.09K | 78.94K | 89.34K |
| Selling & Marketing Expenses | 1.51M | 1.36M | 774.53K | 584.94K | 1.91M | 2.37M | 1M | 467.97K | 503.99K | 1.18M | 578.79K | 172.97K | 232.72K | 199.59K | 407.1K | 35.68K |
| Cost & Expenses | 15.86M | 16.77M | 14.89M | 13.74M | 15.19M | 9.27M | 8.4M | 6.98M | 5.05M | 7.42M | 9.4M | 7.35M | 4.2M | 1.21M | 2.46M | 1.67M |
| Income Tax | n/a | 10.47M | -661.66K | 11.82M | 8.17M | -2.23M | 50.5K | n/a | n/a | 377.72K | 636.5K | 259.35K | 230.37K | n/a | 448.58K | 89.34K |
| Shares Outstanding (Basic) | 4.01M | 3.65M | 2.74M | 597.51K | 143.51K | 64.08K | 31.81K | 14.12K | 1.04K | 618.00 | 586.00 | 277.00 | 85.00 | 37.00 | 30.00 | 27.00 |
| Shares Outstanding (Diluted) | 4.01M | 3.65M | 2.74M | 597.51K | 143.51K | 64.08K | 31.81K | 14.12K | 1.04K | 618.00 | 586.00 | 277.00 | 85.00 | 37.00 | 30.00 | 27.00 |
| EPS (Basic) | -3.48 | -9.92 | -7.16 | -63.1 | -192.02 | -157.4 | -243.5 | -462.31 | -4.6K | -11.06K | -16.05K | -26.79K | -52.79K | -36.56K | -96.41K | -65.28K |
| EPS (Diluted) | -3.48 | -9.92 | -7.16 | -63.1 | -192.02 | -157.4 | -243.5 | -462.31 | -4.6K | -11.06K | -16.05K | -26.79K | -52.79K | -36.56K | -96.41K | -65.28K |
| EBITDA | -13.18M | -13.95M | -12.13M | -11.46M | -12.41M | -7.71M | -5.98M | -6.44M | -4.32M | -6.39M | -8.76M | -7.16M | -4.25M | -1.2M | -2.81M | -1.67M |
| Depreciation & Amortization | 739.32K | 1.31M | 1.34M | 1.02M | 704.88K | 147.63K | 71.56K | 82.36K | 78.57K | 63.04K | 148.76K | 1.08K | 3.17K | 2.43K | 3.04K | 569.00 |